Role of Matrix Metallopeptidase 12 in the Development of Hepatocellular Carcinoma

REFERENCES

• Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115–132. PMID: 26808342. doi:10.3322/caac.21338.
   PubMed Web of Science ®Google Scholar
• Villanueva A, Hoshida Y, Battiston C, et al. Combining clinical, pathology, and gene expression data to predict recurrence of hepatocellular carcinoma. Gastroenterology. 2011;140(5):1501–1512 e2. PMID: 21320499. doi:10.1053/j.gastro.2011.02.006.
   PubMed Web of Science ®Google Scholar
• Bruix J, Boix L, Sala M, Llovet JM. Focus on hepatocellular carcinoma. Cancer Cell. 2004;5(3):215–219. PMID: 15050913.
   PubMed Web of Science ®Google Scholar
• Hassan MM, Hwang LY, Hatten CJ, et al. Risk factors for hepatocellular carcinoma: synergism of alcohol with viral hepatitis and diabetes mellitus. Hepatology. 2002;36(5):1206–1213. PMID: 12395331. doi:10.1053/jhep.2002.36780.
   PubMed Web of Science ®Google Scholar
• Farazi PA, DePinho RA. Hepatocellular carcinoma pathogenesis: from genes to environment. Nat Rev Cancer. 2006;6(9):674–687. PMID: 16929323. doi:10.1038/nrc1934.
   PubMed Web of Science ®Google Scholar
• Shapiro SD, Kobayashi DK, Ley TJ. Cloning and characterization of a unique elastolytic metalloproteinase produced by human alveolar macrophages. J Biol Chem. 1993;268(32):23824–23829.
   PubMed Web of Science ®Google Scholar
• Nagase H, Woessner JF. Jr., Matrix metalloproteinases. J Biol Chem. 1999;274(31):21491–21494. PMID: 10419448. doi:10.1074/jbc.274.31.21491.
   PubMed Web of Science ®Google Scholar
• Kerkela E, Ala-Aho R, Jeskanen L, et al. Expression of human macrophage metalloelastase (MMP-12) by tumor cells in skin cancer. J Invest Dermatol. 2000;114(6):1113–1119. PMID: 10844553. doi:10.1046/j.1523-1747.2000.00993.x.
   PubMed Web of Science ®Google Scholar
• Hu W, Ye Y, Yin Y, et al. Association of matrix metalloprotease 1, 3, and 12 polymorphisms with rheumatic heart disease in a Chinese Han population. BMC Med Genet. 2018;19(1):27. PMID: 29458338. doi:10.1186/s12881-018-0538-4.
   PubMedGoogle Scholar
• Hunninghake GM, Cho MH, Tesfaigzi Y, et al. MMP12, lung function, and COPD in high-risk populations. N Engl J Med. 2009;361(27):2599–2608. PMID: 20018959. doi:10.1056/NEJMoa0904006.
   PubMed Web of Science ®Google Scholar
• Curci JA, Liao S, Huffman MD, Shapiro SD, Thompson RW. Expression and localization of macrophage elastase (matrix metalloproteinase-12) in abdominal aortic aneurysms. J Clin Invest. 1998;102(11):1900–1910. PMID: 9835614. doi:10.1172/JCI2182.
   PubMed Web of Science ®Google Scholar
• Liu C, Zhang C, Jia L, et al. Interleukin-3 stimulates matrix metalloproteinase 12 production from macrophages promoting thoracic aortic aneurysm/dissection. Clin Sci. 2018;132(6):655–668. PMID: 29523595. doi:10.1042/CS20171529.
   PubMed Web of Science ®Google Scholar
• VAN Nguyen S, Skarstedt M, Lofgren S, et al. Gene polymorphism of matrix metalloproteinase-12 and -13 and association with colorectal cancer in Swedish patients. Anticancer Res. 2013;33(8):3247–2350. PMID: 23898086.
   PubMed Web of Science ®Google Scholar
• Lv FZ, Wang JL, Wu Y, Chen HF, Shen XY. Knockdown of MMP12 inhibits the growth and invasion of lung adenocarcinoma cells. Int J Immunopathol Pharmacol. 2015;28(1):77–84. PMID: 25816409. doi:10.1177/0394632015572557.
   PubMed Web of Science ®Google Scholar
• Klupp F, Neumann L, Kahlert C, et al. Serum MMP7, MMP10 and MMP12 level as negative prognostic markers in colon cancer patients. BMC Cancer. 2016;16(1):494. PMID: 27431388. doi:10.1186/s12885-016-2515-7.
   PubMed Web of Science ®Google Scholar
• Han F, Zhang S, Zhang L, Hao Q. The overexpression and predictive significance of MMP-12 in esophageal squamous cell carcinoma. Pathol Res Pract. 2017;213(12):1519–1522. PMID: 29033183. doi:10.1016/j.prp.2017.09.023.
   PubMed Web of Science ®Google Scholar
• Kim JM, Kim HJ, Koo BS, Rha KS, Yoon YH. Expression of matrix metalloproteinase-12 is correlated with extracapsular spread of tumor from nodes with metastasis in head and neck squamous cell carcinoma. Eur Arch Otorhinolaryngol. 2013;270(3):1137–1142. PMID: 22907031. doi:10.1007/s00405-012-2161-x.
   PubMed Web of Science ®Google Scholar
• Cheng P, Jiang FH, Zhao LM, et al. Human macrophage metalloelastase correlates with angiogenesis and prognosis of gastric carcinoma. Dig Dis Sci. 2010;55(11):3138–3146. PMID: 20127415. doi:10.1007/s10620-010-1127-3.
   PubMed Web of Science ®Google Scholar
• Ng KT, Qi X, Kong KL, et al. Overexpression of matrix metalloproteinase-12 (MMP-12) correlates with poor prognosis of hepatocellular carcinoma. Eur J Cancer. 2011;47(15):2299–2305. PMID: 21683576. doi:10.1016/j.ejca.2011.05.032.
   PubMed Web of Science ®Google Scholar
• Ohaegbulam KC, Assal A, Lazar-Molnar E, Yao Y, Zang X. Human cancer immunotherapy with antibodies to the PD-1 and PD-L1 pathway. Trends Mol Med. 2015;21(1):24–33. PMID: 25440090. doi:10.1016/j.molmed.2014.10.009.
   PubMed Web of Science ®Google Scholar
• Chen YB, Mu CY, Huang JA. Clinical significance of programmed death-1 ligand-1 expression in patients with non-small cell lung cancer: a 5-year-follow-up study. Tumori. 2012;98(6):751–755. doi:10.1700/1217.13499. PMID: 23389362.
   PubMed Web of Science ®Google Scholar
• Mu CY, Huang JA, Chen Y, Chen C, Zhang XG. High expression of PD-L1 in lung cancer may contribute to poor prognosis and tumor cells immune escape through suppressing tumor infiltrating dendritic cells maturation. Med Oncol. 2011;28(3):682–688. PMID: 20373055. doi:10.1007/s12032-010-9515-2.
   PubMed Web of Science ®Google Scholar
• Geng Y, Wang H, Lu C, et al. Expression of costimulatory molecules B7-H1, B7-H4 and Foxp3+ Tregs in gastric cancer and its clinical significance. Int J Clin Oncol. 2015;20(2):273–281. PMID: 24804867. doi:10.1007/s10147-014-0701-7.
   PubMed Web of Science ®Google Scholar
• Hou J, Yu Z, Xiang R, et al. Correlation between infiltration of FOXP3+ regulatory T cells and expression of B7-H1 in the tumor tissues of gastric cancer. Exp Mol Pathol. 2014;96(3):284–291. PMID: 24657498. doi:10.1016/j.yexmp.2014.03.005.
   PubMed Web of Science ®Google Scholar
• Hamanishi J, Mandai M, Iwasaki M, et al. Programmed cell death 1 ligand 1 and tumor-infiltrating CD8+ T lymphocytes are prognostic factors of human ovarian cancer. Proc Natl Acad Sci USA. 2007;104(9):3360–3365. PMID: 17360651. doi:10.1073/pnas.0611533104.
   PubMed Web of Science ®Google Scholar
• Hino R, Kabashima K, Kato Y, et al. Tumor cell expression of programmed cell death-1 ligand 1 is a prognostic factor for malignant melanoma. Cancer. 2010;116(7):1757–1766. PMID: 20143437. doi:10.1002/cncr.24899.
   PubMed Web of Science ®Google Scholar
• Loos M, Langer R, Schuster T, et al. Clinical significance of the costimulatory molecule B7-H1 in Barrett carcinoma. The Ann Thorac Surg. 2011;91(4):1025–1031. PMID: 21440117. doi:10.1016/j.athoracsur.2010.12.041.
   PubMed Web of Science ®Google Scholar
• Ohigashi Y, Sho M, Yamada Y, et al. Clinical significance of programmed death-1 ligand-1 and programmed death-1 ligand-2 expression in human esophageal cancer. Clin Cancer Res. 2005;11(8):2947–2953. PMID: 15837746. doi:10.1158/1078-0432.CCR-04-1469.
   PubMed Web of Science ®Google Scholar
• Shi SJ, Wang LJ, Wang GD, et al. B7-H1 expression is associated with poor prognosis in colorectal carcinoma and regulates the proliferation and invasion of HCT116 colorectal cancer cells. PLoS One. 2013;8(10):e76012. PMID: 24124529. doi:10.1371/journal.pone.0076012.
   PubMed Web of Science ®Google Scholar
• Zhu J, Chen L, Zou L, et al. MiR-20b, -21, and -130b inhibit PTEN expression resulting in B7-H1 over-expression in advanced colorectal cancer. Hum Immunol. 2014;75(4):348–353. PMID: 24468585. doi:10.1016/j.humimm.2014.01.006.
   PubMed Web of Science ®Google Scholar
• Gao Q, Wang XY, Qiu SJ, et al. Overexpression of PD-L1 significantly associates with tumor aggressiveness and postoperative recurrence in human hepatocellular carcinoma. Clin Cancer Res. 2009;15(3):971–979. PMID: 19188168. doi:10.1158/1078-0432.CCR-08-1608.
   PubMed Web of Science ®Google Scholar
• Wu K, Kryczek I, Chen L, Zou W, Welling TH. Kupffer cell suppression of CD8+ T cells in human hepatocellular carcinoma is mediated by B7-H1/programmed death-1 interactions. Cancer Res. 2009;69(20):8067–8075. PMID: 19826049. doi:10.1158/0008-5472.CAN-09-0901.
   PubMed Web of Science ®Google Scholar
• Xu L, Chen X, Shen M, et al. Inhibition of IL-6-JAK/Stat3 signaling in castration-resistant prostate cancer cells enhances the NK cell-mediated cytotoxicity via alteration of PD-L1/NKG2D ligand levels. Mol Oncol. 2018;12(3):269–286. PMID: 28865178. doi:10.1002/1878-0261.12135.
   PubMed Web of Science ®Google Scholar
• Liu H, Shen J, Lu K. IL-6 and PD-L1 blockade combination inhibits hepatocellular carcinoma cancer development in mouse model. Biochem Biophys Res Commun. 2017;486(2):239–244. PMID: 28254435. doi:10.1016/j.bbrc.2017.02.128.
   PubMed Web of Science ®Google Scholar
• Chen MF, Chen PT, Chen WC, Lu MS, Lin PY, Lee KD. The role of PD-L1 in the radiation response and prognosis for esophageal squamous cell carcinoma related to IL-6 and T-cell immunosuppression. Oncotarget. 2016;7(7):7913–7924. PMID: 26761210. doi:10.18632/oncotarget.6861.
   PubMedGoogle Scholar
• Li L, Zhang J, Chen J, et al. B-cell receptor-mediated NFATc1 activation induces IL-10/STAT3/PD-L1 signaling in diffuse large B-cell lymphoma. Blood. 2018;132(17):1805. PMID: 30209121. doi:10.1182/blood-2018-03-841015.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Garcia M, Porichis F, de Jong OG, et al. Expression of PD-L1 and PD-L2 on human macrophages is up-regulated by HIV-1 and differentially modulated by IL-10. J Leukoc Biol. 2011;89(4):507–515. PMID: 21097698. doi:10.1189/jlb.0610327.
   PubMed Web of Science ®Google Scholar